155 related articles for article (PubMed ID: 38062011)
21. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
Yao YH; Cui Y; Qiu XN; Zhang LZ; Zhang W; Li H; Yu JM
Chin J Cancer; 2016 Jun; 35():50. PubMed ID: 27266881
[TBL] [Abstract][Full Text] [Related]
22. Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis.
Bai X; Ni J; Beretov J; Wasinger VC; Wang S; Zhu Y; Graham P; Li Y
Redox Biol; 2021 Jul; 43():101993. PubMed ID: 33946018
[TBL] [Abstract][Full Text] [Related]
23. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1.
Lin LC; Lee HT; Chien PJ; Huang YH; Chang MY; Lee YC; Chang WW
Int J Med Sci; 2020; 17(14):2214-2224. PubMed ID: 32922184
[TBL] [Abstract][Full Text] [Related]
24. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
25. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1].
Yang XY; Li N; Deng WY; Ma YJ; Han XL; Zhang ZY; Xie JL; Luo SX
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):193-199. PubMed ID: 30917455
[No Abstract] [Full Text] [Related]
26. A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types.
Dinkelborg PH; Wang M; Gheorghiu L; Gurski JM; Hong TS; Benes CH; Juric D; Jimenez RB; Borgmann K; Willers H
Breast Cancer Res Treat; 2019 Apr; 174(3):605-613. PubMed ID: 30607635
[TBL] [Abstract][Full Text] [Related]
27. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.
Zhang Y; Tian J; Qu C; Peng Y; Lei J; Li K; Zong B; Sun L; Liu S
Breast Cancer; 2021 Jul; 28(4):859-873. PubMed ID: 33569740
[TBL] [Abstract][Full Text] [Related]
29. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Nam SJ; Lee JE
Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
[TBL] [Abstract][Full Text] [Related]
30. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
Chen JH; Kuo KT; Bamodu OA; Lin YC; Yang RB; Yeh CT; Chao TY
Exp Cell Res; 2018 Sep; 370(2):444-453. PubMed ID: 29981340
[TBL] [Abstract][Full Text] [Related]
31. Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer.
Arora R; Yates C; Gary BD; McClellan S; Tan M; Xi Y; Reed E; Piazza GA; Owen LB; Dean-Colomb W
PLoS One; 2014; 9(6):e98370. PubMed ID: 24896091
[TBL] [Abstract][Full Text] [Related]
32. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
[No Abstract] [Full Text] [Related]
33. Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
Kim SH; Hahm ER; Singh KB; Singh SV
Mol Carcinog; 2020 Oct; 59(10):1116-1128. PubMed ID: 32754922
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation.
Zhang H; Zheng J; Fu Y; Ling J; Liu Z; Lin X; Dong X; Sun Y; Tan T; Guo Z; Xie G
Breast Cancer Res Treat; 2023 Apr; 198(3):437-446. PubMed ID: 36797433
[TBL] [Abstract][Full Text] [Related]
35. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
[TBL] [Abstract][Full Text] [Related]
36. The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomas.
Gao M; Shih IeM; Wang TL
Int J Mol Sci; 2012 Oct; 13(11):13881-93. PubMed ID: 23203039
[TBL] [Abstract][Full Text] [Related]
37. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.
Zhang J; Shao X; Sun H; Liu K; Ding Z; Chen J; Fang L; Su W; Hong Y; Li H; Li H
Oncotarget; 2016 Sep; 7(38):61036-61053. PubMed ID: 27506933
[TBL] [Abstract][Full Text] [Related]
38. Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer.
Liu Y; Fang Y; Bao L; Wu F; Wang S; Hao S
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291687
[TBL] [Abstract][Full Text] [Related]
39. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
40. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]